spironolactone has been researched along with Glomerulonephritis, Membranous in 2 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuriyama, S | 1 |
| Sugano, N | 1 |
| Ueda, H | 1 |
| Otsuka, Y | 1 |
| Kanzaki, G | 1 |
| Hosoya, T | 1 |
| LIEBERMAN, ME | 1 |
2 other studies available for spironolactone and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Successful effect of triple blockade of renin-angiotensin-aldosterone system on massive proteinuria in a patient with chronic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Eplerenone; Glome | 2009 |
MEMBRANOUS GLOMERULONEPHRITIS: DISCUSSION AND CASE PRESENTATION.
Topics: Adolescent; Adrenocorticotropic Hormone; Biopsy; Cortisone; Diagnosis; Electrons; Glomerulonephritis | 1964 |